Inspire Corporate Bond ETF (IBD) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Inspire Corporate Bond ETF (IBD) trades at $23.66 with AI Score 44/100 (Grade C). Inspire Corporate Bond ETF (IBD) focuses on investing in investment-grade corporate bonds of biblically aligned U. S. companies. Market cap: $476M, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for IBD: IBD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IBD against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IBD: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Inspire Corporate Bond ETF (IBD) Financial Services Profile
Inspire Corporate Bond ETF (IBD) offers exposure to investment-grade corporate bonds from biblically aligned U.S. companies, tracking the Inspire Corporate Bond Index. With a focus on ethical investing, IBD provides a unique fixed-income option for investors seeking values-based alignment within their portfolios, operating in the competitive asset management landscape.
What Is the Investment Thesis for IBD?
Inspire Corporate Bond ETF (IBD), with a market capitalization of $476M, presents a targeted investment in investment-grade corporate bonds of biblically aligned U.S. companies. The ETF's value proposition lies in its unique ethical screening process and adherence to the Inspire Corporate Bond Index. A key growth catalyst is the increasing investor demand for ESG (Environmental, Social, and Governance) and values-based investment products. However, the fund's performance is subject to interest rate risk and credit risk associated with the underlying bonds. Ongoing monitoring of the fund's expense ratio and tracking error relative to its benchmark is crucial for assessing its long-term value. The absence of a dividend yield may deter some income-seeking investors.
Based on FMP financials and quantitative analysis
IBD Key Highlights
Market capitalization of $476M indicates a moderate size within the ETF market.
- Beta of 0.65 suggests lower volatility compared to the overall market, potentially appealing to risk-averse investors.
- Focus on investment-grade corporate bonds provides a relatively stable fixed-income investment.
- Ethical screening process aligns with the growing demand for values-based investing.
- Replicates the Inspire Corporate Bond Index, offering a transparent and rules-based investment approach.
Who Are IBD's Competitors?
IBD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BGRN iShares USD Green Bond ETF | $46.89 | -0.25% | $500M | 44 |
| FDHY FIDELITY ENHANCED HIGH YIELD ETF | $49.15 | -0.02% | $542M | 44 |
| HYEM VanEck Emerging Markets High Yield Bond ETF | $20.03 | -0.05% | $535M | 44 |
| HYGH iShares Interest Rate Hedged High Yield Bond ETF | $86.45 | -0.09% | $548M | 44 |
| IBTL iShares iBonds Dec 2031 Term Treasury ETF | $20.02 | -0.15% | $578M | 44 |
| FTMU Franklin Municipal Income ETF | $7.73 | -0.51% | $463M | 49 |
| ISD PGIM High Yield Bond Fund, Inc. | $12.29 | -0.89% | $410M | 80 |
| PHB Invesco Fundamental High Yield Corporate Bond ETF | $18.71 | +0.00% | $381M | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IBD's Key Strengths?
Unique focus on biblically aligned companies.
- Growing demand for ESG investments.
- Transparent and rules-based investment approach.
- Relatively stable fixed-income investment.
What Are IBD's Weaknesses?
Limited investment universe compared to broad-based bond ETFs.
- Potential for higher expense ratio due to ethical screening process.
- Lack of dividend yield may deter some investors.
- Vulnerability to interest rate risk.
What Could Drive IBD Stock Higher?
Increasing investor demand for ESG and values-based investments.
- Growing awareness of biblically responsible investing (BRI) principles.
- Potential for new partnerships with faith-based organizations.
- Launch of new ethically screened investment products.
What Are the Key Risks for IBD?
Interest rate risk associated with fixed-income investments.
- Credit risk related to the underlying corporate bonds.
- Competition from larger asset managers with lower expense ratios.
- Changes in the Inspire Corporate Bond Index methodology.
- Market volatility and economic uncertainty.
What Are the Growth Opportunities for IBD?
- Expansion of ESG Investing: The increasing focus on ESG (Environmental, Social, and Governance) factors in investment decisions presents a significant growth opportunity for IBD. As more investors seek to align their portfolios with their values, the demand for ethically screened bond funds is likely to rise. IBD can capitalize on this trend by further promoting its biblically responsible investing (BRI) approach and attracting investors seeking values-based fixed-income options.
- Partnerships with Faith-Based Organizations: Collaborating with faith-based organizations and financial advisors can expand IBD's reach to a wider audience of values-driven investors. By partnering with religious institutions, charities, and other organizations that share its values, IBD can tap into established networks and build trust with potential investors. This strategy can involve offering educational resources, hosting webinars, and participating in conferences and events focused on faith and finance. Successful partnerships can significantly increase IBD's visibility and market share within the faith-based investment community.
- Development of New Ethically Screened Products: Expanding its product line to include other ethically screened fixed-income and equity ETFs can attract a broader range of investors. By offering a suite of investment products that align with different risk profiles and investment objectives, IBD can cater to a wider segment of the values-based market. This can involve launching ETFs focused on specific sectors, such as healthcare or technology, or developing diversified portfolios that combine ethically screened stocks and bonds. Innovation in product development can enhance IBD's competitiveness and brand recognition within the ESG investment landscape.
- Increased Marketing and Awareness Campaigns: Implementing targeted marketing campaigns to raise awareness of IBD's unique value proposition can attract new investors. This can involve utilizing social media, online advertising, and public relations to communicate the fund's ethical screening process and investment performance. Highlighting the positive impact of investing in biblically aligned companies can resonate with values-driven investors and differentiate IBD from its competitors. Effective marketing can increase investor interest and drive asset growth for the fund.
- Geographic Expansion: While currently focused on U.S. companies, expanding the investment universe to include international companies that meet Inspire Investing's ethical criteria can broaden IBD's appeal to global investors. This can involve developing new indices and ETFs that track the performance of biblically aligned companies in other countries or regions. Geographic expansion can diversify IBD's portfolio and tap into new markets with growing demand for ESG investments. However, it also requires careful consideration of regulatory and cultural differences in different countries.
What Threats Does IBD Face?
- Competition from larger asset managers with broader product offerings.
- Changes in interest rates and credit spreads.
- Regulatory changes impacting ESG investing.
- Negative publicity related to companies in the portfolio.
What Are IBD's Competitive Advantages?
- Unique ethical screening process based on biblical values.
- Alignment with the Inspire Corporate Bond Index.
- Brand recognition within the faith-based investment community.
- First-mover advantage in the biblically responsible investing (BRI) space.
What Does IBD Do?
The Inspire Corporate Bond ETF (IBD) was created to provide investors with a fixed-income investment option that aligns with biblically responsible investing (BRI) principles. The fund invests in investment-grade corporate bonds issued by U.S. companies that meet specific criteria related to their adherence to biblical values. IBD seeks to replicate the performance of the Inspire Corporate Bond Index, which is designed to select companies that demonstrate a commitment to these values. The ETF's investment strategy involves screening potential investments based on factors such as corporate governance, environmental stewardship, and social responsibility, as defined by Inspire Investing's BRI framework. By focusing on investment-grade bonds, IBD aims to provide a relatively stable and lower-risk fixed-income option compared to high-yield or emerging market debt. The fund's portfolio typically includes bonds from a diverse range of sectors, reflecting the broad universe of U.S. corporations that meet Inspire Investing's ethical criteria. IBD's unique approach to fixed-income investing has attracted investors who prioritize both financial returns and alignment with their values.
What Products and Services Does IBD Offer?
- Invests in investment-grade corporate bonds.
- Focuses on companies aligned with biblical values.
- Tracks the Inspire Corporate Bond Index.
- Provides exposure to U.S. corporate debt market.
- Offers a fixed-income investment option.
- Screens companies based on ethical criteria.
- Aims to provide stable returns with lower risk.
How Does IBD Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- Invests in a diversified portfolio of investment-grade corporate bonds.
- Utilizes a rules-based approach to select companies that meet ethical criteria.
- Replicates the performance of the Inspire Corporate Bond Index.
What Industry Does IBD Operate In?
The Inspire Corporate Bond ETF (IBD) operates within the asset management industry, specifically focusing on fixed-income investments. The industry is characterized by a wide range of investment strategies, including passive and active management, as well as specialized approaches such as ESG investing. The competitive landscape includes large asset managers offering broad-based bond ETFs, as well as smaller firms specializing in niche strategies. Market trends include increasing demand for ESG investments, driven by growing awareness of social and environmental issues. IBD differentiates itself through its unique focus on biblically aligned companies, catering to a specific segment of values-based investors.
Who Are IBD's Key Customers?
- Individual investors seeking values-based investments.
- Financial advisors looking for ethically screened fixed-income options.
- Faith-based organizations and institutions.
- ESG-focused investors.
Key Financial Metrics
Return on equity for Inspire Corporate Bond ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. IBD trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
How Inspire Corporate Bond ETF Is Valued
Inspire Corporate Bond ETF carries a market capitalization of $476M, placing it in the small-cap category. Relative to its peer group, IBD's quantitative score of 44/100 is roughly in line with the peer average of 44/100.
IBD Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the ETF's long-term performance, indicating that key stakeholders believe in its potential.
- Community sentiment has shifted positively, with discussions highlighting the ETF's resilience amidst market volatility.
- Investors are increasingly drawn to corporate bonds as a safer investment alternative, benefiting ETFs like IBD.
- Recent commentary on the stability of corporate bonds supports a bullish outlook, as more investors seek yield in uncertain times.
Bear Case
- Concerns about rising interest rates could pressure bond prices, leading to skepticism about the ETF's short-term performance.
- Some community members express doubts regarding the ETF's ability to outperform traditional equity markets, highlighting potential opportunity costs.
- Recent market developments have led to increased caution among investors, with some viewing corporate bonds as less attractive.
- The ETF's performance is heavily dependent on corporate credit quality, and any negative news could impact investor sentiment significantly.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
IBD Latest News
No recent news available for IBD.
IBD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IBD.
Price Targets
Wall Street price target analysis for IBD.
IBD MoonshotScore
What does this score mean?
The MoonshotScore rates IBD 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
What Investors Ask About Inspire Corporate Bond ETF (IBD) — Financial Services
What does the AI Score mean for IBD?
IBD holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Inspire Corporate Bond ETF (IBD) focuses on investing in investment-grade corporate bonds of biblically aligned U.S. companies. The ETF aims to mirror the performance of the Inspire Corporate Bond …
What does Inspire Corporate Bond ETF do?
Inspire Corporate Bond ETF (IBD) is a passively managed exchange-traded fund that invests in investment-grade corporate bonds issued by biblically aligned U.S. companies. The fund seeks to replicate the performance of the Inspire Corporate Bond Index, which screens companies based on their adherence to biblical values.
What are the main risks for IBD?
The main risks for Inspire Corporate Bond ETF (IBD) include interest rate risk, which can negatively impact the fund's value when interest rates rise. Credit risk is also a concern, as the fund invests in corporate bonds that are subject to default risk.
What are the key factors to evaluate for IBD?
Inspire Corporate Bond ETF (IBD) holds an AI score of 44/100 (low). Inspire Corporate Bond ETF (IBD), with a market capitalization of $476M, presents a targeted investment in investment-grade corporate bonds of biblically aligned U.S. Not financial advice.
How frequently does IBD data refresh on this page?
IBD's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven IBD's recent stock price performance?
Inspire Corporate Bond ETF (IBD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Unique focus on biblically aligned companies. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IBD overvalued or undervalued right now?
Inspire Corporate Bond ETF (IBD) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research IBD before investing?
Before investing in Inspire Corporate Bond ETF (IBD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding IBD to a portfolio?
Key strength of Inspire Corporate Bond ETF (IBD): Unique focus on biblically aligned companies. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for IBD.
- Information is based on available data and may be subject to change.